This pops out to me for a few reasons. Nice run this year. Net income a big negative, minus 83.3 mil. Have like 4 sell triggers/strat's on it already. Can see wave force up exhaustion. What's interesting is the near neckline support and then the gap. Just looks like its priming up to drop. Do your own due diligence. If x occurs do x1 if y occurs do Y1. Imagine different scenarios, take the one that confirms. They are a Gene Therapy play and do have some fast track designation for AMT-130 for treatment of Huntingtons disease. It is a hot sector. Could also be bought out. Probably going up on that hopium. Technically, could get interesting if those supports break. I'll be looking close if they break. If that was a five min intraday chart I'de be all over it scalping. Bio's are tricky, volatile. Caution. If I do get in this short I'll be scalping it down on a fast moving down support break. I don't like to hang around in these. To responsive to managed news. When it gets to these points of decision they are often pumped with news or something. Would be looking for that, but if they don't have any ammo it could get interesting.
코멘트:
Should probably check around and see how that clinical trial is going on AMT130.
코멘트:
check out MDB..